Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include HIV/AIDS Research and Interventions, HIV, Drug Use, Sexual Risk, Hepatitis C virus research, and HIV-related health complications and treatments.
The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study
Impact of HLA class I functional divergence on HIV control
Effectiveness of mRNA Booster Vaccine Against Coronavirus Disease 2019 Infection and Severe Outcomes Among Persons With and Without Immune Dysfunction: A Retrospective Cohort Study of National Electronic Medical Record Data in the United States
Africa-specific human genetic variation near CHD1L associates with HIV-1 load
Detecting Liver Cancer Using Cell-Free DNA Fragmentomes
Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US
Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data
Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015
Risk of HCC With Hepatitis B Viremia Among HIV/HBV‐Coinfected Persons in North America
Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada
HLA tapasin independence: broader peptide repertoire and HIV control
Ending the HIV epidemic in the USA: an economic modelling study in six cities
The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US Cities
Hospitalization Rates and Causes Among Persons With HIV in the United States and Canada, 2005–2015
Identifying the immune interactions underlying HLA class I disease associations
Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities
Nonstructured Treatment Interruptions Are Associated With Higher Human Immunodeficiency Virus Reservoir Size Measured by Intact Proviral DNA Assay in People Who Inject Drugs
Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies
CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome
Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study
Development and Calibration of a Dynamic HIV Transmission Model for 6 US Cities
Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia With Anal Cancer Risk in Persons Living With HIV in the United States and Canada
Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia
Elevated <i>HLA-A</i> expression impairs HIV control through inhibition of NKG2A-expressing cells
Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy
Inhibitory killer cell immunoglobulin-like receptors strengthen CD8 <sup>+</sup> T cell–mediated control of HIV-1, HCV, and HTLV-1
Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States
Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis
Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras
Cumulative Incidence of Cancer Among Persons With HIV in North America